Significant Accounting Policies (Details Textual) - TG Therapeutics, Inc. [Member] |
Feb. 02, 2018
USD ($)
|
|---|---|
| Revenues | $ 50,000 |
| Intellectual Property [Member] | |
| Finite-Lived Intangible Asset, Useful Life | 180 years |
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|